Hofstädter F - Search Results

1

Gender-dependent cancer-specific survival following radical cystectomy.

May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M. May M, et al. Among authors: hofstadter f. World J Urol. 2012 Oct;30(5):707-13. doi: 10.1007/s00345-011-0773-1. Epub 2011 Oct 9. World J Urol. 2012. PMID: 21984471

2

Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.

Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W. Denzinger S, et al. Among authors: hofstadter f. Scand J Urol Nephrol. 2009;43(4):282-7. doi: 10.1080/00365590902854354. Scand J Urol Nephrol. 2009. PMID: 19382004

3

Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.

Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S. Otto W, et al. Among authors: hofstadter f. Pathol Res Pract. 2011 Mar 15;207(3):161-3. doi: 10.1016/j.prp.2010.12.006. Epub 2011 Jan 17. Pathol Res Pract. 2011. PMID: 21247708

4

Solitary and small (≤3 mm) apical positive surgical margins are related to biochemical recurrence after radical prostatectomy.

May M, Brookman-May S, Weißbach L, Herbst H, Gilfrich C, Papadopoulos T, Roigas J, Hofstädter F, Wieland WF, Burger M. May M, et al. Among authors: hofstadter f. Int J Urol. 2011 Apr;18(4):282-9. doi: 10.1111/j.1442-2042.2011.02736.x. Epub 2011 Feb 22. Int J Urol. 2011. PMID: 21342298

5

Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.

Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A. Bertz S, et al. Among authors: hofstadter f. Eur Urol. 2014 Jan;65(1):218-26. doi: 10.1016/j.eururo.2012.05.033. Epub 2012 May 19. Eur Urol. 2014. PMID: 22633802

6

Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.

Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S. Otto W, et al. Among authors: hofstadter f. BMC Cancer. 2012 Oct 8;12:459. doi: 10.1186/1471-2407-12-459. BMC Cancer. 2012. PMID: 23043286 Free PMC article.

7

Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.

Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. Fritsche HM, et al. Among authors: hofstadter f. Eur Urol. 2013 Apr;63(4):739-44. doi: 10.1016/j.eururo.2012.09.053. Epub 2012 Sep 28. Eur Urol. 2013. PMID: 23079053

8

Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.

May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S. May M, et al. Among authors: hofstadter f. BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10. BJU Int. 2013. PMID: 23305250

9

Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.

Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A. Breyer J, et al. Among authors: hofstadter f. Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4. Urol Int. 2014. PMID: 25196313

10

Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.

Breyer J, Gierth M, Shalekenov S, Aziz A, Schäfer J, Burger M, Denzinger S, Hofstädter F, Giedl C, Otto W. Breyer J, et al. Among authors: hofstadter f. World J Urol. 2016 May;34(5):709-16. doi: 10.1007/s00345-015-1690-5. Epub 2015 Sep 22. World J Urol. 2016. PMID: 26394624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page